Thirman, Michael J.

Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia

DiNardo, C. D., Jonas, B. A., Pullarkat, V., Thirman, M. J., Garcia, J. S., Wei, A. H., Konopleva, M., Döhner, H., Letai, A., Fenaux, P., et al. (2020) · New England Journal of Medicine

Acute Myeloid Leukemia ResearchRetinoids in leukemia and cellular processes

Cited by 2,900

Clonal evolution underlying leukemia progression and Richter transformation in patients with ibrutinib-relapsed CLL

Kadri, S., Lee, J., Fitzpatrick, C., Galanina, N., Sukhanova, M., Venkataraman, G., Sharma, S., Long, B., Petras, K., Theissen, M., et al. (2017) · Blood Advances

Chronic Lymphocytic Leukemia ResearchAcute Myeloid Leukemia Research

Cited by 133

Treatment outcomes of venetoclax-combination regimens for relapsed/refractory myeloid malignancies after anti-CD47-directed therapy

Madero-Marroquin, R., Dworkin, E., Weiner, H., Saygin, C., Nawas, M. T., Drazer, M. W., DuVall, A. S., Kosuri, S., Thirman, M. J., Odenike, O., et al. (2024) · Leukemia & Lymphoma

Acute Myeloid Leukemia ResearchChronic Lymphocytic Leukemia Research

Cited by 2